GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Dividend Payout Ratio : 3.48 (As of Jun. 2023)

View and export this data going back to 2001. Start your Free Trial

What is GlaxoSmithKline Consumer Nigeria Dividend Payout Ratio?

GlaxoSmithKline Consumer Nigeria's dividend payout ratio for the months ended in Jun. 2023 was 3.48.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of GlaxoSmithKline Consumer Nigeria PLC is 1.04, which seems too high.

The historical rank and industry rank for GlaxoSmithKline Consumer Nigeria's Dividend Payout Ratio or its related term are showing as below:

NSA:GLAXOSMITH' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.15 Med: 0.67 Max: 1.04
Current: 1.04

During the past 13 years, the highest Dividend Payout Ratio of GlaxoSmithKline Consumer Nigeria was 1.04. The lowest was 0.15. And the median was 0.67.

NSA:GLAXOSMITH's Dividend Payout Ratio is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.33 vs NSA:GLAXOSMITH: 1.04

As of today (2024-05-25), the Dividend Yield % of GlaxoSmithKline Consumer Nigeria is 3.24%.

During the past 13 years, the highest Trailing Annual Dividend Yield of GlaxoSmithKline Consumer Nigeria was 14.49%. The lowest was 0.88%. And the median was 4.71%.

GlaxoSmithKline Consumer Nigeria's Dividends per Share for the months ended in Jun. 2023 was ₦0.55.

During the past 12 months, GlaxoSmithKline Consumer Nigeria's average Dividends Per Share Growth Rate was 150.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -3.50% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 6.30% per year. During the past 10 years, the average Dividends Per Share Growth Rate was -8.70% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of GlaxoSmithKline Consumer Nigeria was 22.40% per year. The lowest was -33.90% per year. And the median was -7.90% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

GlaxoSmithKline Consumer Nigeria Dividend Payout Ratio Historical Data

The historical data trend for GlaxoSmithKline Consumer Nigeria's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Consumer Nigeria Dividend Payout Ratio Chart

GlaxoSmithKline Consumer Nigeria Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dividend Payout Ratio

Get a 7-Day Free Trial

0.66

0.65

0.99

0.71

0.67

GlaxoSmithKline Consumer Nigeria Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23
Dividend Payout Ratio	Get a 7-Day Free Trial															-	3.29	-	-	3.48

Competitive Comparison of GlaxoSmithKline Consumer Nigeria's Dividend Payout Ratio

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Consumer Nigeria's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GlaxoSmithKline Consumer Nigeria's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Consumer Nigeria's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Consumer Nigeria's Dividend Payout Ratio falls into.

GlaxoSmithKline Consumer Nigeria Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

GlaxoSmithKline Consumer Nigeria's Dividend Payout Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2022 )	/	EPS without NRI (A: Dec. 2022 )
	=	0.45	/	0.67
	=	0.67

GlaxoSmithKline Consumer Nigeria's Dividend Payout Ratio for the quarter that ended in Jun. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jun. 2023 )	/	EPS without NRI (Q: Jun. 2023 )
	=	0.55	/	0.158
	=	3.48

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

GlaxoSmithKline Consumer Nigeria Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Consumer Nigeria's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, Industrial Avenue, Ilupeju, P.M.B. 21218, Ikeja, GSK House, Lagos, NGA

Website

https://www.ng.gsk.com

GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Headlines

No Headlines